novartis glp 1 Readout Newsletter: Novartis, Eli Lilly, Amgen, and Gilead The GLP-1 Revolution: From Diabetes
Description
Without adequate protein intake and strength training, GLP-1 medications can lead to loss of lean mass along with fat
Some people maintain most of their results long-term
As appetite decreases, having a simple system in place makes it easier to stay on track without overthinking your daily intake
DOI : 10.1186/s12905-024-03235-4
Clinical impact
